InsidersTradesSigma
Track the Jamjoom Pharma share price and the full insider trade history of the company, a publicly traded company based in Saudi Arabia. Shares trade on the SA market, under the authority of Tadawul (CMA). Operating in the Health Care sector, Jamjoom Pharma has published 1 public disclosures. Market capitalisation: €10.3bn. The latest transaction was reported on 4 July 2023 (Board / executive change). All data is free.
Analysts rate Jamjoom Pharma Hold (neutral), based on 3 analysts. Average price target: SAR 164.24.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Jamjoom Pharma is a company focused on health and pharmaceuticals, providing a range of pharmaceutical products. It is listed on the XSAU market.